The 11 references without contexts in paper E. Kosolapov G., F. Kochenkov S., N. Pogudina L., D. Blinov V., Е. Косолапов Г., Ф. Коченков С., Н. Погудина Л., Д. Блинов В. (2017) “Клинико-экономический анализ применения комбинированного препарата вилантерол + умеклидиния бромид для терапии хронической обструктивной болезни легких тяжелого и крайне тяжелого течения по сравнению с монотерапией препаратом тиотропия бромид // COST-EFFECTIVENESS OF VILANEROL / UMECLIDINIUM VERSUS TIOTROPIUM IN SEVERE AND VERY SEVERE COPD” / spz:neicon:pharmacoeconomics:y:2017:i:2:p:31-40

1
Ovcharenko S. I. Lechebnoe Delo. 2004; 2: 24-30.
(check this in PDF content)
2
Gershon A. S. et al. Forecasting Health Services Use In Individuals With Chronic Obstructive Pulmonary Disease (COPD): A Time-Series Analysis //C96. Global Perspectives on COPD Burden and Care Delivery. American Thoracic Society. 2016; A6159-A6159.
(check this in PDF content)
3
Mannino D. M. et al. Continuing to Confront COPD International Patient Survey: methods, COPD prevalence, and disease burden in 2012–2013. International Journal of COPD. 2014; 9: 597-611.
(check this in PDF content)
4
Crighton E. J. et al. A spatial analysis of COPD prevalence, incidence, mortality and health service use in Ontario. Health reports. 2015; 26 (3): 10.
(check this in PDF content)
5
Evans J. et al. Estimating the prevalence of COPD in Canada: Reported diagnosis versus measured airflow obstruction. Health reports. 2014; 25 (3): 3.
(check this in PDF content)
18
Anoro Ellipta. Instructions for medical use. State Drug Register [Instruktsiya po meditsinskomu primeneniyu. Gosudarstvennyi reestr Lekarstvennykh Sredstv (in Russian)]. URL: www.grls.rosminzdrav.ru. Accessed: 15.12.2016.
(check this in PDF content)
19
Spiriva Respimat. Instructions for medical use. State Drug Register [Instruktsiya po meditsinskomu primeneniyu. Gosudarstvennyi reestr Lekarstvennykh Sredstv (in Russian)]. URL: www.grls. rosminzdrav.ru. Accessed: 15.12.2016.
(check this in PDF content)
20
Global strategy for diagnosis, treatment and prevention of chronic obstructive pulmonary disease (revision 2014) / Trans. With English. Ed. A. S. Belevsky [Global’naya strategiya diagnostiki, lecheniya i profilaktiki khronicheskoi obstruktivnoi bolezni legkikh (peresmotr 2014 g.) / Per. s angl. pod red. A. S. Belevskogo (in Russian)]. Moscow. 2014; 92 s.
(check this in PDF content)
21
Chronic obstructive pulmonary disease. Clinical recommendations [Khronicheskaya obstruktivnaya bolezn’ legkikh. Klinicheskie rekomendatsii (in Russian)]. Moscow. 2016; 69 s.
(check this in PDF content)
22
Makarova E. V., Shumilova S. V., Vakhlamov V. A., Kasatova E. S., Menkov N. V., Lukovnikova N. B., Varvarina G. N., Tyurikova L. V., Karaulov A. V., Novikov V. V. Effect of noninvasive ventilation on functional and immune parameters in patients with severe exacerbation of chronic obstructive pulmonary disease. [Vliyanie neinvazivnoj ventilyacii legkih na funkcional’nye i immunnye pokazateli u bol’nyh s tyazhelym obostreniem hronicheskoj obstruktivnoj bolezni legkih]. Klinicheskaya Medicina. 2017; 95 (4): 344-349 (in Russian).
(check this in PDF content)
23
Makarova E. V., Varvarina G. N., Menkov N. V., Tsapaeva M. Yu., Lazareva E. S., Kazatskaya Zh. A., Novikov V. V., Karaulov A. V. Nebulized budesonide in the treatment of exacerbations of chronic obstructive pulmonary disease: efficacy, safety and effect on the content of soluble differentiation molecules in serum. [Nebulizirovannyj
(check this in PDF content)